Litcius/Paper detail

Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV

Filippo Pietrantonio, Francesca Bergamo, Daniele Rossini, Filippo Ghelardi, Maria Caterina De Grandis, Marco Maria Germani, Giulia Barsotti, Vincenzo Formica, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Lorenzo Antonuzzo, Carlotta Antoniotti, Margherita Ambrosini, Vittoria Matilde Piva, Federico Nichetti, Matteo Fassan, Chiara Cremolini, Sara Lonardi

2023European Journal of Cancer18 citationsDOIOpen Access PDF

Topics & Concepts

PanitumumabMedicinePTENInternal medicineFOLFOXColorectal cancerOncologyExonKRASROS1CancerGastroenterologyAdenocarcinomaOxaliplatinGeneBiologyGeneticsPI3K/AKT/mTOR pathwayApoptosisColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsCancer Genomics and Diagnostics
Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV | Litcius